EBMT Data Office ▲ Sign in to save

• ▲ Małgorzata Mikulska

  European Society for Blood and Marrow Transplantation · Ospedale Policlinico San Martino Medicine
  13.5k

  citations

  58

  h-index

  3

  Aachen papers
• ▲ Anja van Biezen

  Leiden University Medical Center · European Society for Blood and Marrow Transplantation Medicine
  7.23k

  citations

  49

  h-index

  13

  Aachen papers
• ▲ Gloria Tridello

  European Society for Blood and Marrow Transplantation Medicine
  5.2k

  citations

  35

  h-index

  23

  Aachen papers
• ▲ Linda Köster

  Leiden University · National Taiwan University Medicine
  1.84k

  citations

  23

  h-index

  109

  Aachen papers
• ▲ Jennifer Hoek

  European Society for Blood and Marrow Transplantation · European Society for Blood and Marrow Transplantation Medicine
  1.15k

  citations

  11

  h-index

  8

  Aachen papers
• ▲ Nina Simone Knelange

  European Society for Blood and Marrow Transplantation Medicine
  1.06k

  citations

  17

  h-index

  44

  Aachen papers
• ▲ Steffie Maria van der Werf

  European Society for Blood and Marrow Transplantation Medicine
  951

  citations

  14

  h-index

  11

  Aachen papers
• ▲ Paul V. Bosman

  European Society for Blood and Marrow Transplantation Medicine
  468

  citations

  10

  h-index

  13

  Aachen papers
• ▲ Tiarlan Sirait

  Medicine
  457

  citations

  10

  h-index

  14

  Aachen papers
• ▲ Lotus Wendel

  European Society for Blood and Marrow Transplantation Medicine
  256

  citations

  10

  h-index

  21

  Aachen papers
• ▲ Nienke Zinger

  Netherlands Institute for Health Services Research Medicine
  229

  citations

  8

  h-index

  14

  Aachen papers
• ▲ Laurien G.A. Baaij

  Leiden University · European Society for Blood and Marrow Transplantation Medicine
  115

  citations

  4

  h-index

  15

  Aachen papers
• ▲ Anne Lippinkhof‐Kozijn

  European Society for Blood and Marrow Transplantation Medicine
  7

  citations

  1

  h-index

  1

  Aachen papers

13 results

• Post-Transplant Cyclophosphamide for Graft Vs Host Disease Prophylaxis in Multiple Myeloma Patients Who Underwent Allogeneic Hematopoietic Cell Transplantation: First Comparison By Donor Type; A Study from the Chronic Malignancies Working Party of the EBMT

  2020 Blood article Medicine Hematopoietic Stem Cell Transplantation Open access

  1

  citations
• Gvhd and Relapse Free Survival (GRFS) after Allogeneic Transplantation for Idiopathic Severe Aplastic Anemia: An Analysis from the Saawp Data Quality Initiative Program of EBMT

  2020 Blood article Medicine Hematopoietic Stem Cell Transplantation

  1

  citations
• Correction: Long-term outcome after allogeneic hematopoietic stem cell transplantation for Shwachman–Diamond syndrome: a retrospective analysis and a review of the literature by the Severe Aplastic Anemia Working Party of the European Society for Blood and Marrow Transplantation (SAAWP-EBMT)

  2020 Bone Marrow Transplantation erratum Biochemistry, Genetics and Molecular Biology Blood disorders and treatments Open access

  1

  citations
• Daratumumab after Allogeneic Hematopoietic Stem Cell Transplantation in Multiple Myeloma: Safety and Efficacy. a Retrospective Study from the Cmwp EBMT

  2020 Blood article Medicine Multiple Myeloma Research and Treatments

  0

  citations
• Prognostic impact of early‐versus‐late responses to different induction regimens in patients with myeloma undergoing autologous hematopoietic cell transplantation: Results from the CALM study by the CMWP of the EBMT

  2021 European Journal Of Haematology article Medicine Multiple Myeloma Research and Treatments Open access

  0

  citations
• Impact of Specific Adverse Cytogenetic Features on Outcomes after Allogeneic Hematopoietic Cell Transplantation in Myelodysplastic Syndrome with Very Poor Risk Cytogenetics: A Study from the Chronic Malignancies Working Party of EBMT

  2021 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Characteristics and Outcomes of Newly Diagnosed Multiple Myeloma Patients with and without Extramedullary Disease after Autologous Transplant and Maintenance Therapy: A Study from the Cmwp-EBMT

  2021 Blood conference-abstract Medicine Multiple Myeloma Research and Treatments

  0

  citations
• Comparative Study of Unrelated and Haploidentical Donor Hematopoietic Cell Transplant for Chronic Myeloid Leukemia with Post Transplant Cyclophosphamide As Graft-Versus-Host Disease Prophylaxis: A Study from the Chronic Malignancies Working Party of EBMT

  2021 Blood conference-abstract Medicine Hematopoietic Stem Cell Transplantation

  0

  citations
• Correction: Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey

  2021 Bone Marrow Transplantation erratum Medicine Lymphoma Diagnosis and Treatment Open access

  0

  citations
• Correction to: Allogeneic hematopoietic cell transplantation for patients with TP53 mutant or deleted chronic lymphocytic leukemia: results of a prospective observational study

  2021 Bone Marrow Transplantation erratum Medicine Chronic Lymphocytic Leukemia Research Open access

  0

  citations
• Correction to: Idelalisib treatment prior to allogeneic stem cell transplantation for patients with chronic lymphocytic leukemia: a report from the EBMT chronic malignancies working party

  2021 Bone Marrow Transplantation erratum Medicine Chronic Lymphocytic Leukemia Research Open access

  0

  citations
• Impact of Post-transplant cyclophosphamide (PTCy)-Based Prophylaxis in Matched Sibling Donor Allogeneic Haematopoietic Cell Transplantation for Patients with Myelodysplastic Syndrome: A Retrospective Study on Behalf of the Chronic Malignancies Working Party of the EBMT

  2023 Research Square preprint Medicine Hematopoietic Stem Cell Transplantation Open access

  0

  citations
• In the era of Bortezomib-based Induction, intensification of Melphalan-based conditioning with Bortezomib does not improve Survival Outcomes in newly diagnosed Multiple Myeloma: a study from the Chronic Malignancies Working Party of the EBMT

  2023 Research Square preprint Medicine Multiple Myeloma Research and Treatments Open access

  0

  citations
• 485. Improved Outcome of COVID-19 in CAR T Cell Treated Patients; results of a multicenter study on behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

  2023 Open Forum Infectious Diseases article Medicine COVID-19 Clinical Research Studies Open access cited by 1 patent

  0

  citations
• Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A retrospective study of Infectious Disease Working Party of EBMT

  2025 Research Square preprint Medicine Cytomegalovirus and herpesvirus research Open access

  0

  citations
• Length of SARS-CoV-2 shedding in HCT recipients: an Infectious Disease Working Party of EBMT study

  2026 Bone Marrow Transplantation article Medicine SARS-CoV-2 and COVID-19 Research

  0

  citations